| Surgical treatment of doxorubicin-induced heart failure. | |
| | |
MedLine Citation:
|
PMID: 20072969 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Doxorubicin-induced heart failure is a rare, but serious illness and is well-known to be difficult to treat. Prevention strategies have not demonstrated the expected success and unfortunately, this specific type of heart failure does not respond to the usual medical therapies as do other kinds of heart failure. Therefore, surgical procedures may be necessary in some patients. Cardiac transplantation is performed in most cases but this requires cure of the neoplastic disease. This usually requires a recurrence-free interval of several years which is associated with a high attrition rate in these patients due to their cardiac disease. Therefore, ventricular assist devices may be implanted in selected patients as a bridge to transplantation or destination therapy. This review focuses on the surgical options for doxorubicin-induced heart failure and discusses their efficacy as well as their clinical applicability. |
| | |
Authors:
|
S Christiansen |
Related Documents
:
|
16076689 - Increased circulating endothelins are not of cardiopulmonary origin in heart failure pa... 8603129 - Coronary beta-adrenoceptor function is modified by the endothelium in heart failure. 18324939 - Validation of the chinese version of the macnew heart disease health-related quality of... 23438549 - Mitral annulus reconstruction and giant left atrial reduction plasty. 8305279 - Cardiac effects of coronary arteriography with electrolyte addition to iohexol. a study... 19808269 - Osteopontin, a new prognostic biomarker in patients with chronic heart failure. 121799 - Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. 16502169 - Percutaneous valve replacement: significance of different delivery systems in vitro and... 20545999 - Ventricular asynchrony of time-to-peak systolic velocity in structurally normal heart b... |
Publication Detail:
|
Type: Journal Article; Review Date: 2010-01-13 |
Journal Detail:
|
Title: The Thoracic and cardiovascular surgeon Volume: 58 ISSN: 1439-1902 ISO Abbreviation: Thorac Cardiovasc Surg Publication Date: 2010 Feb |
Date Detail:
|
Created Date: 2010-01-14 Completed Date: 2010-03-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7903387 Medline TA: Thorac Cardiovasc Surg Country: Germany |
Other Details:
|
Languages: eng Pagination: 8-10 Citation Subset: IM |
Affiliation:
|
Department of Cardiac Surgery, Campus Universit?tsklinikum Schleswig-Holstein, L?beck, Germany. stefanchristiansen@arcor.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibiotics, Antineoplastic
/
adverse effects* Doxorubicin / adverse effects* Heart Failure / chemically induced*, surgery* Heart Transplantation Heart-Assist Devices Humans Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antibiotics, Antineoplastic; 23214-92-8/Doxorubicin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Impact of lymphatic vessels on the heart.
Next Document: Transmyocardial laser revascularization combined with intramyocardial endothelial progenitor cell tr...